Skip to content

Clinical trials

Trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Country / region: Austria Clear all

7,802 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200034
200150
200280
200397
2004141
2005167
2006243
2007269
2008317
2009307
2010339
2011355
2012351
2013320
2014328
2015327
2016301
2017413
2018376
2019387
2020426
2021450
2022336
2023357
2024345
2025303
2026222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4,695
Recruiting857
Unknown status709
Terminated684
Active, not recruiting597
Withdrawn91
Not yet recruiting86
Enrolling by invitation46
Suspended17
No longer available11
Approved for marketing7
Temporarily not available1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Vienna994
Medical University of Graz434
Novartis Pharmaceuticals250
Hoffmann-La Roche201
Bayer171
Medical University Innsbruck168
Boehringer Ingelheim160
AstraZeneca142
Bristol-Myers Squibb134
Eli Lilly and Company130

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms216
Diabetes Mellitus, Type 2168
Carcinoma, Non-Small-Cell Lung161
Neoplasms156
Diabetes Mellitus133
Heart Failure133
Atrial Fibrillation101
Diabetes Mellitus, Type 1101
Crohn Disease100
Colorectal Neoplasms99

Trials

Showing 26 to 50 of 7,802. Each trial links to its page on Pharma Observatory.

7,702 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.